Cancer of the head and neck
PTEN as a prognostic and predictive marker in postoperative radiotherapy for squamous cell cancer of the head and neck.
8
Rev. LatinoAm. Enfermagem vol.20 número2
7
5-Methyltetrahydrofolate-homocysteine methyltransferase gene polymorphism (MTR) and risk of head and neck cancer
6
Braz. j. . vol.78 número1 en v78n1a21
8
Influence of handling conditions on the establishment and propagation of head and neck cancer patient derived xenografts.
10
CoDAS vol.26 número3
1
J. bras. pneumol. vol.40 número3
8
Multivariate analyses to assess the effects of surgeon and hospital volume on cancer survival rates: a nationwide population-based study in Taiwan.
10
EVALUATION OF HEMATOLOGICAL PARAMETERS AS A POSSIBLE MARKER FOR HEAD-AND-NECK CANCER AND PRECANCEROUS CONDITIONS
6
Epidemiological and microbiological aspects of oral mucositis in head and neck cancer patients during radiotherapy / Aspectos epidemiológicos e microbiológicos da mucosite oral em pacientes com câncer na região de cabeça e pescoço durante a radioterapia
18
Rev. CEFAC vol.17 número4
8
Rev. CEFAC vol.15 número4
9
Overexpression of prothymosin alpha predicts poor disease outcome in head and neck cancer.
10
Nosheen Masood and Mahmood Akhtar Kayani
6
Meta-analysis of MMP2, MMP3, and MMP9 promoter polymorphisms and head and neck cancer risk.
10
Rev. Bras. . vol.74 número1 en a11v74n1
6
Rev. LatinoAm. Enfermagem vol.24
9
Inhibition of STAT3 by niclosamide synergizes with erlotinib against head and neck cancer.
13
Ensaio clínico randomizado fase III da eficácia do betanecol no tratamento da xerostomia em pacientes com neoplasias malignas das vias aerodigestivas superiores submetidos à radioterapia
65
Clinical analysis of 152 cases of multiple primary malignant tumors in 15,398 patients with malignant tumors.
8